Related Experiment Video
Updated: Jun 12, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Risk of SARS-CoV-2 Infection and Hospitalisation in Immunocompromised Children: A Population-Based Cohort Study in
Costanza Di Chiara1,2,3, Riccardo Boracchini4, Nhung T H Trinh5
1Department for Women's and Children's Health, University of Padua, Padua, Italy.
Insights
Immunocompromised children (IC) did not face higher SARS-CoV-2 infection risks. However, IC children showed increased hospitalisation rates, suggesting precautionary management rather than greater disease severity.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Immunocompromised children (IC) were presumed at higher risk for SARS-CoV-2 infection and severe COVID-19.
- Limited population-based evidence exists regarding COVID-19 outcomes in pediatric populations with compromised immune systems.
Purpose of the Study:
- To assess SARS-CoV-2 infection risk, COVID-19 hospitalization rates, and severe outcomes in immunocompromised children (IC) compared to children with other high-risk conditions (non-IC) and reference children (RC).
Main Methods:
- Retrospective population-based cohort study utilizing electronic health registries from Italy and Norway (February 2020-February 2022).
- Included children aged 1-14 years, classified into IC, non-IC, and RC groups.
- Adjusted models were used to estimate infection and hospitalization risks.
Main Results:
- Infection rates were similar across all groups in both countries.
- Hospitalizations were rare overall. In Norway, adjusted hazard ratios for hospitalization were 5.29 (IC vs. RC) and 2.30 (IC vs. non-IC).
- Severe COVID-19 cases were low (zero in Italy, five in Norway).
Conclusions:
- Immunocompromised children (IC) did not exhibit an increased risk of SARS-CoV-2 infection.
- IC children experienced higher hospitalization rates, potentially due to precautionary clinical management rather than increased disease severity.
- The study highlights the need for careful monitoring and management strategies for immunocompromised children during viral outbreaks.
Aim:
Immunocompromised children (IC) were presumed to be at higher risk of SARS-COV-2 infection and severe COVID-19, but population-based evidence is limited. We assessed infection risk, COVID-19 hospitalisation, and severe outcomes in IC compared with children with and without other high-risk conditions.
Methods:
We conducted a retrospective population-based cohort study using electronic health registries from Italy and Norway, including children aged 1-14 years from February 2020-February 2022. Children were classified as IC, non-immunocompromised with high-risk conditions (non-IC), or reference children (RC). Adjusted models estimated infection hospitalisation risks.
Results:
We included 29 520 children (IC = 201, non-IC = 5 144, RC = 24 175) in Italy and 851 517 (IC = 4 862, non-IC = 157 358, RC = 689 297) in Norway. Infection rates were similar across groups in both countries. Hospitalisations were rare in both datasets; however, in the Norwegian cohort, the aHR for hospitalisation was 5.29 (95% CI: 2.49-11.25) for IC vs. RC and 2.30 (95% CI: 1.10-4.82) for IC vs. non-IC. Zero and five severe cases occurred in Italy and Norway, respectively.
Conclusions:
IC did not have an increased risk of infection but experienced higher hospitalisation rates despite a low incidence of severe disease. This pattern may reflect precautionary clinical management rather than increased disease severity.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Bias in Epidemiological Studies
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease

